Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children

Shaffiq M. Essajee, Mimi Kim, Charles Gonzalez, Mona Rigaud, Aditya Kaul, Sulachni Chandwani, William Hoover, Robert Lawrence, Hans Spiegel, Henry Pollack, Keith Krasinski, William Borkowsky

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Objective: To determine the long-term immunologic and virologic effects of highly active antiretroviral therapy (HAART) in children with AIDS. Design: A prospective observational study. Setting: Two pediatric HIV clinics. Participants: Twenty-five protease-inhibitor naive HIV-infected children (aged 2-18 years) with advanced disease (CD4 ≤ 6%). Intervention: HAART (one protease inhibitor and one or more nucleoside analogs). Diphtheria and tetanus immunization in six patients after 18 months of therapy. Main outcome measures: Changes in percentage of CD4 cells and plasma HIV-1 RNA levels; post-treatment assays of lymphoproliferative responses to recall antigens; CD4 cell memory phenotype. Results: Median duration of follow-up was 18.8 months (range, 7.5-28 months). At baseline the CD4 cell percentage was 2% (range, 0-6%), this increased significantly to 16% (range, 3-48%) above baseline at 12 months (P = 0.002). The mean maximum CD4 cell increase was 20.7% (range 4-48%) which corresponds to 657 x 106 cells/l (range, 30-2240 x 106 cells/l) above baseline. By contrast, the median viral load was not significantly lower at 12 months than at baseline (P = 0.34), and only 25% of the patients had sustained undetectable viral load. Of the reconstituted CD4 cells 70% were naive, and none of the subjects had lymphoproliferative responses to tetanus and diphtheria although 40% did develop responses to Candida, an environmental antigen. A single immunization with diphtheria and tetanus toxoid produced lymphoproliferative responses to tetanus in three out of six patients. Conclusions: HAART was associated with sustained increases in CD4 cell counts, despite a high incidence of 'virologic failure'. CD4 counts and the proportion of naive cells were higher than have been reported in adults, which may be a reflection of greater thymic activity in children. Memory cell clones for antigens encountered in the past which are not prevalent before therapy could not be expanded without additional antigenic exposure.

Original languageEnglish (US)
Pages (from-to)2523-2532
Number of pages10
JournalAIDS
Volume13
Issue number18
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
HIV-1
Tetanus
Diphtheria
CD4 Lymphocyte Count
Viral Load
Antigens
Immunization
Diphtheria Toxoid
HIV Protease Inhibitors
Tetanus Toxoid
Plasma Cells
Protease Inhibitors
Candida
Nucleosides
Observational Studies
Acquired Immunodeficiency Syndrome
Therapeutics
Clone Cells
Outcome Assessment (Health Care)

Keywords

  • Highly active antretroviral therapy (HAART)
  • Pediatric AIDS

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Essajee, S. M., Kim, M., Gonzalez, C., Rigaud, M., Kaul, A., Chandwani, S., ... Borkowsky, W. (1999). Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. AIDS, 13(18), 2523-2532. https://doi.org/10.1097/00002030-199912240-00005

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. / Essajee, Shaffiq M.; Kim, Mimi; Gonzalez, Charles; Rigaud, Mona; Kaul, Aditya; Chandwani, Sulachni; Hoover, William; Lawrence, Robert; Spiegel, Hans; Pollack, Henry; Krasinski, Keith; Borkowsky, William.

In: AIDS, Vol. 13, No. 18, 1999, p. 2523-2532.

Research output: Contribution to journalArticle

Essajee, SM, Kim, M, Gonzalez, C, Rigaud, M, Kaul, A, Chandwani, S, Hoover, W, Lawrence, R, Spiegel, H, Pollack, H, Krasinski, K & Borkowsky, W 1999, 'Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children', AIDS, vol. 13, no. 18, pp. 2523-2532. https://doi.org/10.1097/00002030-199912240-00005
Essajee, Shaffiq M. ; Kim, Mimi ; Gonzalez, Charles ; Rigaud, Mona ; Kaul, Aditya ; Chandwani, Sulachni ; Hoover, William ; Lawrence, Robert ; Spiegel, Hans ; Pollack, Henry ; Krasinski, Keith ; Borkowsky, William. / Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. In: AIDS. 1999 ; Vol. 13, No. 18. pp. 2523-2532.
@article{9f19c21e2775409db17383ab458a61f0,
title = "Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children",
abstract = "Objective: To determine the long-term immunologic and virologic effects of highly active antiretroviral therapy (HAART) in children with AIDS. Design: A prospective observational study. Setting: Two pediatric HIV clinics. Participants: Twenty-five protease-inhibitor naive HIV-infected children (aged 2-18 years) with advanced disease (CD4 ≤ 6{\%}). Intervention: HAART (one protease inhibitor and one or more nucleoside analogs). Diphtheria and tetanus immunization in six patients after 18 months of therapy. Main outcome measures: Changes in percentage of CD4 cells and plasma HIV-1 RNA levels; post-treatment assays of lymphoproliferative responses to recall antigens; CD4 cell memory phenotype. Results: Median duration of follow-up was 18.8 months (range, 7.5-28 months). At baseline the CD4 cell percentage was 2{\%} (range, 0-6{\%}), this increased significantly to 16{\%} (range, 3-48{\%}) above baseline at 12 months (P = 0.002). The mean maximum CD4 cell increase was 20.7{\%} (range 4-48{\%}) which corresponds to 657 x 106 cells/l (range, 30-2240 x 106 cells/l) above baseline. By contrast, the median viral load was not significantly lower at 12 months than at baseline (P = 0.34), and only 25{\%} of the patients had sustained undetectable viral load. Of the reconstituted CD4 cells 70{\%} were naive, and none of the subjects had lymphoproliferative responses to tetanus and diphtheria although 40{\%} did develop responses to Candida, an environmental antigen. A single immunization with diphtheria and tetanus toxoid produced lymphoproliferative responses to tetanus in three out of six patients. Conclusions: HAART was associated with sustained increases in CD4 cell counts, despite a high incidence of 'virologic failure'. CD4 counts and the proportion of naive cells were higher than have been reported in adults, which may be a reflection of greater thymic activity in children. Memory cell clones for antigens encountered in the past which are not prevalent before therapy could not be expanded without additional antigenic exposure.",
keywords = "Highly active antretroviral therapy (HAART), Pediatric AIDS",
author = "Essajee, {Shaffiq M.} and Mimi Kim and Charles Gonzalez and Mona Rigaud and Aditya Kaul and Sulachni Chandwani and William Hoover and Robert Lawrence and Hans Spiegel and Henry Pollack and Keith Krasinski and William Borkowsky",
year = "1999",
doi = "10.1097/00002030-199912240-00005",
language = "English (US)",
volume = "13",
pages = "2523--2532",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "18",

}

TY - JOUR

T1 - Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children

AU - Essajee, Shaffiq M.

AU - Kim, Mimi

AU - Gonzalez, Charles

AU - Rigaud, Mona

AU - Kaul, Aditya

AU - Chandwani, Sulachni

AU - Hoover, William

AU - Lawrence, Robert

AU - Spiegel, Hans

AU - Pollack, Henry

AU - Krasinski, Keith

AU - Borkowsky, William

PY - 1999

Y1 - 1999

N2 - Objective: To determine the long-term immunologic and virologic effects of highly active antiretroviral therapy (HAART) in children with AIDS. Design: A prospective observational study. Setting: Two pediatric HIV clinics. Participants: Twenty-five protease-inhibitor naive HIV-infected children (aged 2-18 years) with advanced disease (CD4 ≤ 6%). Intervention: HAART (one protease inhibitor and one or more nucleoside analogs). Diphtheria and tetanus immunization in six patients after 18 months of therapy. Main outcome measures: Changes in percentage of CD4 cells and plasma HIV-1 RNA levels; post-treatment assays of lymphoproliferative responses to recall antigens; CD4 cell memory phenotype. Results: Median duration of follow-up was 18.8 months (range, 7.5-28 months). At baseline the CD4 cell percentage was 2% (range, 0-6%), this increased significantly to 16% (range, 3-48%) above baseline at 12 months (P = 0.002). The mean maximum CD4 cell increase was 20.7% (range 4-48%) which corresponds to 657 x 106 cells/l (range, 30-2240 x 106 cells/l) above baseline. By contrast, the median viral load was not significantly lower at 12 months than at baseline (P = 0.34), and only 25% of the patients had sustained undetectable viral load. Of the reconstituted CD4 cells 70% were naive, and none of the subjects had lymphoproliferative responses to tetanus and diphtheria although 40% did develop responses to Candida, an environmental antigen. A single immunization with diphtheria and tetanus toxoid produced lymphoproliferative responses to tetanus in three out of six patients. Conclusions: HAART was associated with sustained increases in CD4 cell counts, despite a high incidence of 'virologic failure'. CD4 counts and the proportion of naive cells were higher than have been reported in adults, which may be a reflection of greater thymic activity in children. Memory cell clones for antigens encountered in the past which are not prevalent before therapy could not be expanded without additional antigenic exposure.

AB - Objective: To determine the long-term immunologic and virologic effects of highly active antiretroviral therapy (HAART) in children with AIDS. Design: A prospective observational study. Setting: Two pediatric HIV clinics. Participants: Twenty-five protease-inhibitor naive HIV-infected children (aged 2-18 years) with advanced disease (CD4 ≤ 6%). Intervention: HAART (one protease inhibitor and one or more nucleoside analogs). Diphtheria and tetanus immunization in six patients after 18 months of therapy. Main outcome measures: Changes in percentage of CD4 cells and plasma HIV-1 RNA levels; post-treatment assays of lymphoproliferative responses to recall antigens; CD4 cell memory phenotype. Results: Median duration of follow-up was 18.8 months (range, 7.5-28 months). At baseline the CD4 cell percentage was 2% (range, 0-6%), this increased significantly to 16% (range, 3-48%) above baseline at 12 months (P = 0.002). The mean maximum CD4 cell increase was 20.7% (range 4-48%) which corresponds to 657 x 106 cells/l (range, 30-2240 x 106 cells/l) above baseline. By contrast, the median viral load was not significantly lower at 12 months than at baseline (P = 0.34), and only 25% of the patients had sustained undetectable viral load. Of the reconstituted CD4 cells 70% were naive, and none of the subjects had lymphoproliferative responses to tetanus and diphtheria although 40% did develop responses to Candida, an environmental antigen. A single immunization with diphtheria and tetanus toxoid produced lymphoproliferative responses to tetanus in three out of six patients. Conclusions: HAART was associated with sustained increases in CD4 cell counts, despite a high incidence of 'virologic failure'. CD4 counts and the proportion of naive cells were higher than have been reported in adults, which may be a reflection of greater thymic activity in children. Memory cell clones for antigens encountered in the past which are not prevalent before therapy could not be expanded without additional antigenic exposure.

KW - Highly active antretroviral therapy (HAART)

KW - Pediatric AIDS

UR - http://www.scopus.com/inward/record.url?scp=0033386546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033386546&partnerID=8YFLogxK

U2 - 10.1097/00002030-199912240-00005

DO - 10.1097/00002030-199912240-00005

M3 - Article

C2 - 10630521

AN - SCOPUS:0033386546

VL - 13

SP - 2523

EP - 2532

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 18

ER -